StockData
ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31

ENCISION INC

Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 13, 2025
$0.01+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$163.15K
P/E (TTM)
–
Dividend yield
–

ENCISION INC revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Product [Member]$1.48M$1.49M$1.51M$1.46M$1.65M$1.59M$1.50M$1.56M$1.75M$1.61M$1.80M$1.68M97.0%-10.4%
Service [Member]$46.25K$109.90K$68.91K$128.18K$101.57K$38.97K$19.64K$20.46K$73.98K$39.83K$4.72K$03.0%-54.5%
Products [Member]–––$1.46M$1.65M$1.59M–$1.56M$1.75M$1.61M–$1.68M––
Services [Member]–––$128.18K$101.57K$38.97K–$20.46K$73.98K$39.83K–$0––

By region

From the segment and revenue-disaggregation notes of Encision's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.